DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

U.S. Army Medical Research and Materiel Command &
Fort Detrick Public Affairs/Marketing Office, Fort Detrick, Maryland


December 22, 2003

Department of Defense Tuberous Sclerosis Complex Research Program Funding Opportunities for Fiscal Year 2004

The Fiscal Year 2004 (FY04) Defense Appropriations Act provides $3 million to the Department of Defense Tuberous Sclerosis Complex Research Program (TSCRP) to support innovative research directed toward improved prevention, diagnosis, and treatment for tuberous sclerosis. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

The FY04 TSCRP Program Announcements will be released in mid to late January 2004, with receipt of electronic submission proposals due May 4, 2004 at 5:00 p.m. Eastern time.

FY04 TSCRP Program Announcements for proposals in the following mechanisms are expected to be released mid to late January 2004:

  • Concept Awards - New
  • Natural History Development Awards - New
  • Idea Development Awards

The New Concept Awards are intended to fund exploration of an initial concept or theory that could give rise to a testable hypothesis within tuberous sclerosis research. The Congressionally Directed Medical Research Programs (CDMRP) plans to solicit electronic submissions for short (three-page) Concept Award proposals. Preliminary data are not required. These awards can be requested for $100,000 inclusive of direct and indirect costs over a one year performance period. Projects involving human subjects or human anatomical substances will not be supported unless they are exempt (full details will be available in the Program Announcement). The receipt deadline for proposal submissions is planned for May 4, 2004, 5:00 p.m. Eastern time.

The New Natural History Development Awards are intended to fund the development of natural history studies of tumor growth and/or other manifestations of tuberous sclerosis. These awards will fund the development of a plan for communication, data transfer, handling of specimens, and imaging products, and a plan for statistical analysis between collaborating institutions and laboratories. The submission of a Natural History Award application will be required at the conclusion of the award period. Funding for the Natural History Development Awards will provide up to $100,000 inclusive of direct and indirect costs for up to a one year performance period. The receipt deadline for proposal submissions is planned for May 4, 2004, 5:00 p.m. Eastern time.

Idea Development Awards are designed to encourage innovative research directed toward improved prevention, diagnosis, and/or treatment of tuberous sclerosis. They are intended to stimulate and reward innovative research ideas that may be viewed as high risk but have the potential for high gain in scientific and clinical knowledge. Idea Development Awards are for a maximum of $425,000 inclusive of direct and indirect costs for a 2 to 3 year performance period. The receipt deadline for proposal submissions is planned for May 4, 2004, 5:00 p.m. Eastern time.

Detailed descriptions of each of these mechanisms, evaluation criteria, and submission requirements, and deadlines will be available in the relevant FY04 TSCRP Program Announcement when released in mid to late January. Each Program Announcement will be available electronically as a download from the CDMRP web site http://cdmrp.army.mil upon its release.

Requests for e-mail notification when Program Announcements are released may be sent to prequest@constellagroup.com. For more information about the TSCRP, TSCRP awardees, previous TSCRP Program Announcements, and other CDMRP-sponsored programs and events, please visit the CDMRP web site: http://cdmrp.army.mil.

Points of Contact:

Gail Whitehead, Public Affairs Coordinator, 301-619-7783, gail.whitehead@amedd.army.mil
Richard Kenyon, Ph.D., Program Manager TSCRP, 301-619-7071